140 related articles for article (PubMed ID: 26043836)
21. Picropodophyllin inhibits the growth of Ewing's sarcoma cells through the insulin‑like growth factor‑1 receptor/Akt signaling pathway.
Wu YT; Wang BJ; Miao SW; Gao JJ
Mol Med Rep; 2015 Nov; 12(5):7045-50. PubMed ID: 26323364
[TBL] [Abstract][Full Text] [Related]
22. RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status.
Sonnemann J; Grauel D; Blümel L; Hentschel J; Marx C; Blumrich A; Focke K; Becker S; Wittig S; Schinkel S; Krämer OH; Beck JF
Eur J Cancer; 2015 May; 51(7):841-51. PubMed ID: 25801700
[TBL] [Abstract][Full Text] [Related]
23. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
24. microRNA and Bone Cancer.
Nugent M
Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
[TBL] [Abstract][Full Text] [Related]
25. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
26. Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing's sarcoma.
Shi X; Wu Y; Tang L; Ni H; Xu Y
Aging (Albany NY); 2023 Mar; 15(6):2321-2346. PubMed ID: 36988561
[TBL] [Abstract][Full Text] [Related]
27. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
von Heyking K; Roth L; Ertl M; Schmidt O; Calzada-Wack J; Neff F; Lawlor ER; Burdach S; Richter GH
Oncotarget; 2016 Jul; 7(27):41767-41780. PubMed ID: 27363011
[TBL] [Abstract][Full Text] [Related]
28. The miR-146b-5p promotes Ewing's sarcoma cells progression via suppressing the expression of BTG2.
Qu L; Zhang W; Li J; Liu P
Sci Prog; 2021; 104(2):368504211002043. PubMed ID: 33844600
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
30. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
Liu W; Liu SY; He YB; Huang RL; Deng SY; Ni GX; Yu B
Biomed Pharmacother; 2017 Mar; 87():621-627. PubMed ID: 28086136
[TBL] [Abstract][Full Text] [Related]
31. Prediction of high risk Ewing's sarcoma by gene expression profiling.
Ohali A; Avigad S; Zaizov R; Ophir R; Horn-Saban S; Cohen IJ; Meller I; Kollender Y; Issakov J; Yaniv I
Oncogene; 2004 Nov; 23(55):8997-9006. PubMed ID: 15467746
[TBL] [Abstract][Full Text] [Related]
32. IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.
Lissat A; Joerschke M; Shinde DA; Braunschweig T; Meier A; Makowska A; Bortnick R; Henneke P; Herget G; Gorr TA; Kontny U
BMC Cancer; 2015 Jul; 15():552. PubMed ID: 26215971
[TBL] [Abstract][Full Text] [Related]
33. Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize.
Sáinz-Jaspeado M; Lagares-Tena L; Lasheras J; Navid F; Rodriguez-Galindo C; Mateo-Lozano S; Notario V; Sanjuan X; Garcia Del Muro X; Fabra A; Tirado OM
Mol Cancer Res; 2010 Nov; 8(11):1489-500. PubMed ID: 21106507
[TBL] [Abstract][Full Text] [Related]
34. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
35. Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review.
Hassan M; Shahzadi S; Malik A; Din SU; Yasir M; Chun W; Kloczkowski A
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895198
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma.
Pan B; Bu X; Cao M; Zhang X; Huo T; Li Z; Gao X; Jing L; Luo X; Feng H; Yuan F; Guo K
J Cancer Res Clin Oncol; 2021 Feb; 147(2):393-401. PubMed ID: 33104883
[TBL] [Abstract][Full Text] [Related]
37. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
[TBL] [Abstract][Full Text] [Related]
38. G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1.
Richter GH; Fasan A; Hauer K; Grunewald TG; Berns C; Rössler S; Naumann I; Staege MS; Fulda S; Esposito I; Burdach S
J Pathol; 2013 May; 230(1):70-81. PubMed ID: 23338946
[TBL] [Abstract][Full Text] [Related]
39. Interaction of arsenic trioxide and etoposide in Ewing sarcoma cell lines.
Lenz JE; Riester R; Schleicher SB; Handgretinger R; Boehme KA; Traub F
Oncol Rep; 2020 Jan; 43(1):337-345. PubMed ID: 31746397
[TBL] [Abstract][Full Text] [Related]
40. Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.
Aryee DN; Niedan S; Ban J; Schwentner R; Muehlbacher K; Kauer M; Kofler R; Kovar H
Br J Cancer; 2013 Nov; 109(10):2696-704. PubMed ID: 24129240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]